Global Botanical Drug Market Size, Share, Trends and Forecast 2022-2030

Description

Sales outsourcing is simply this: outsourcing a portion or entire sales activities to a trusted 3rd party sales team. Using a sales outsourcing partner allows companies to attract and maintain a sales force without having to make them full or part-time employees.
Industry Insights

The global Botanical Drug market size is projected to reach US$ 43150 million by 2028, from US$ 32680 million in 2021, at a CAGR of 4.0% during 2022-2028.

Buchang Pharmaceuticals, China TCM, Tsumura, Schwabe, Tong Ren Tang, Jumpcan Pharmaceutical, Guangzhou Baiyunshan Pharmaceutical, etc. are the leaders of the industry.

Asia-Pacific is the largest consumption place, with a consumption market share nearly 75% in 2019. Following Asia-Pacific, Europe is the second largest consumption place with the consumption market share of about 16%.

The classification of Botanical Drug includes Prescription Drug and OTC, and the proportion of OTC in 2019 was about 61%.

Botanical Drug is widely used for Cardiovascular, Tumor, Respiratory System, Others. The most proportion of Botanical Drug is Cardiovascular, and the proportion in 2019 was 30%.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Botanical Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Botanical Drug market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Botanical Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Botanical Drug market.

Impact of Covid-19 Outbreak

This section of the report has explored the overall status of the Covid scenario and has offered valuable insights into the changes in supply chain disruption, fluctuations in demand, etc. The analysts have also focused on the key measures that the companies are opting to withstand the harsh scenario.

Segmental Analysis

The report has been segmented into product and application segments. The researchers have documented all the products present today in the Botanical Drug market. They have also shed light on the new product innovations and launches by the key players. In the segmental analysis, the analysts have provided revenue forecast figures based on type and application for the period 2017-2028. They have also discussed about the growth rate and potential of each segment for the period 2017-2028.

Botanical Drug Breakdown Data by Type

Prescription Drug

OTC

Botanical Drug Breakdown Data by Application

Cardiovascular

Tumor

Respiratory System

Others

Regional Analysis

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Competitive Landscape

This segment focuses on the key players operating in the industry. It underlines all the current and future activities by the prominent manufacturers. By understanding various initiatives being taken up by different players, readers will gain the ability to settle on correct business choices. The authors of the report have provided accurate revenue figures of the companies for the period 2017-2022. The clients are sure to gain the upper hand once they get hold of this report. Key players studied in the research report include:

Buchang Pharmaceuticals

China TCM

Tsumura

Schwabe

Tong Ren Tang

Jumpcan Pharmaceutical

Guangzhou Baiyunshan Pharmaceutical

Yunnan Baiyao

Tasly Holding Group

Bionorica Se

Huarun 999

Taiji

Weleda

Kwangdong

GW Pharmaceuticals

TABLE OF CONTENT

1 Report Overview
1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Botanical Drug Market Size Growth Rate by Type: 2017 VS 2021 VS 2028

1.2.2 Prescription Drug

1.2.3 OTC

1.3 Market by Application

1.3.1 Global Botanical Drug Market Share by Application: 2017 VS 2021 VS 2028

1.3.2 Cardiovascular

1.3.3 Tumor

1.3.4 Respiratory System

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global Botanical Drug Market Perspective (2017-2028)

2.2 Botanical Drug Growth Trends by Region

2.2.1 Botanical Drug Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Botanical Drug Historic Market Size by Region (2017-2022)

2.2.3 Botanical Drug Forecasted Market Size by Region (2023-2028)

2.3 Botanical Drug Market Dynamics

2.3.1 Botanical Drug Industry Trends

2.3.2 Botanical Drug Market Drivers

2.3.3 Botanical Drug Market Challenges

2.3.4 Botanical Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Botanical Drug Players by Revenue

3.1.1 Global Top Botanical Drug Players by Revenue (2017-2022)

3.1.2 Global Botanical Drug Revenue Market Share by Players (2017-2022)

3.2 Global Botanical Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Botanical Drug Revenue

3.4 Global Botanical Drug Market Concentration Ratio

3.4.1 Global Botanical Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Botanical Drug Revenue in 2021

3.5 Botanical Drug Key Players Head office and Area Served

3.6 Key Players Botanical Drug Product Solution and Service

3.7 Date of Enter into Botanical Drug Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Botanical Drug Breakdown Data by Type

4.1 Global Botanical Drug Historic Market Size by Type (2017-2022)

4.2 Global Botanical Drug Forecasted Market Size by Type (2023-2028)

5 Botanical Drug Breakdown Data by Application

5.1 Global Botanical Drug Historic Market Size by Application (2017-2022)

5.2 Global Botanical Drug Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America Botanical Drug Market Size (2017-2028)

6.2 North America Botanical Drug Market Size by Country (2017-2022)

6.3 North America Botanical Drug Market Size by Country (2023-2028)

6.4 United States

6.5 Canada

7 Europe

7.1 Europe Botanical Drug Market Size (2017-2028)

7.2 Europe Botanical Drug Market Size by Country (2017-2022)

7.3 Europe Botanical Drug Market Size by Country (2023-2028)

7.4 Germany

7.5 France

7.6 U.K.

7.7 Italy

7.8 Russia

7.9 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Botanical Drug Market Size (2017-2028)

8.2 Asia-Pacific Botanical Drug Market Size by Country (2017-2022)

8.3 Asia-Pacific Botanical Drug Market Size by Country (2023-2028)

8.4 China

8.5 Japan

8.6 South Korea

8.7 Southeast Asia

8.8 India

8.9 Australia

9 Latin America

9.1 Latin America Botanical Drug Market Size (2017-2028)

9.2 Latin America Botanical Drug Market Size by Country (2017-2022)

9.3 Latin America Botanical Drug Market Size by Country (2023-2028)

9.4 Mexico

9.5 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Botanical Drug Market Size (2017-2028)

10.2 Middle East & Africa Botanical Drug Market Size by Country (2017-2022)

10.3 Middle East & Africa Botanical Drug Market Size by Country (2023-2028)

10.4 Turkey

10.5 Saudi Arabia

10.6 UAE

11 Key Players Profiles

11.1 Buchang Pharmaceuticals

11.1.1 Buchang Pharmaceuticals Company Detail

11.1.2 Buchang Pharmaceuticals Business Overview

11.1.3 Buchang Pharmaceuticals Botanical Drug Introduction

11.1.4 Buchang Pharmaceuticals Revenue in Botanical Drug Business (2017-2022)

11.1.5 Buchang Pharmaceuticals Recent Development

11.2 China TCM

11.2.1 China TCM Company Detail

11.2.2 China TCM Business Overview

11.2.3 China TCM Botanical Drug Introduction

11.2.4 China TCM Revenue in Botanical Drug Business (2017-2022)

11.2.5 China TCM Recent Development

11.3 Tsumura

11.3.1 Tsumura Company Detail

11.3.2 Tsumura Business Overview

11.3.3 Tsumura Botanical Drug Introduction

11.3.4 Tsumura Revenue in Botanical Drug Business (2017-2022)

11.3.5 Tsumura Recent Development

11.4 Schwabe

11.4.1 Schwabe Company Detail

11.4.2 Schwabe Business Overview

11.4.3 Schwabe Botanical Drug Introduction

11.4.4 Schwabe Revenue in Botanical Drug Business (2017-2022)

11.4.5 Schwabe Recent Development

11.5 Tong Ren Tang

11.5.1 Tong Ren Tang Company Detail

11.5.2 Tong Ren Tang Business Overview

11.5.3 Tong Ren Tang Botanical Drug Introduction

11.5.4 Tong Ren Tang Revenue in Botanical Drug Business (2017-2022)

11.5.5 Tong Ren Tang Recent Development

11.6 Jumpcan Pharmaceutical

11.6.1 Jumpcan Pharmaceutical Company Detail

11.6.2 Jumpcan Pharmaceutical Business Overview

11.6.3 Jumpcan Pharmaceutical Botanical Drug Introduction

11.6.4 Jumpcan Pharmaceutical Revenue in Botanical Drug Business (2017-2022)

11.6.5 Jumpcan Pharmaceutical Recent Development

11.7 Guangzhou Baiyunshan Pharmaceutical

11.7.1 Guangzhou Baiyunshan Pharmaceutical Company Detail

11.7.2 Guangzhou Baiyunshan Pharmaceutical Business Overview

11.7.3 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Introduction

11.7.4 Guangzhou Baiyunshan Pharmaceutical Revenue in Botanical Drug Business (2017-2022)

11.7.5 Guangzhou Baiyunshan Pharmaceutical Recent Development

11.8 Yunnan Baiyao

11.8.1 Yunnan Baiyao Company Detail

11.8.2 Yunnan Baiyao Business Overview

11.8.3 Yunnan Baiyao Botanical Drug Introduction

11.8.4 Yunnan Baiyao Revenue in Botanical Drug Business (2017-2022)

11.8.5 Yunnan Baiyao Recent Development

11.9 Tasly Holding Group

11.9.1 Tasly Holding Group Company Detail

11.9.2 Tasly Holding Group Business Overview

11.9.3 Tasly Holding Group Botanical Drug Introduction

11.9.4 Tasly Holding Group Revenue in Botanical Drug Business (2017-2022)

11.9.5 Tasly Holding Group Recent Development

11.10 Bionorica Se

11.10.1 Bionorica Se Company Detail

11.10.2 Bionorica Se Business Overview

11.10.3 Bionorica Se Botanical Drug Introduction

11.10.4 Bionorica Se Revenue in Botanical Drug Business (2017-2022)

11.10.5 Bionorica Se Recent Development

11.11 Huarun 999

11.11.1 Huarun 999 Company Detail

11.11.2 Huarun 999 Business Overview

11.11.3 Huarun 999 Botanical Drug Introduction

11.11.4 Huarun 999 Revenue in Botanical Drug Business (2017-2022)

11.11.5 Huarun 999 Recent Development

11.12 Taiji

11.12.1 Taiji Company Detail

11.12.2 Taiji Business Overview

11.12.3 Taiji Botanical Drug Introduction

11.12.4 Taiji Revenue in Botanical Drug Business (2017-2022)

11.12.5 Taiji Recent Development

11.13 Weleda

11.13.1 Weleda Company Detail

11.13.2 Weleda Business Overview

11.13.3 Weleda Botanical Drug Introduction

11.13.4 Weleda Revenue in Botanical Drug Business (2017-2022)

11.13.5 Weleda Recent Development

11.14 Kwangdong

11.14.1 Kwangdong Company Detail

11.14.2 Kwangdong Business Overview

11.14.3 Kwangdong Botanical Drug Introduction

11.14.4 Kwangdong Revenue in Botanical Drug Business (2017-2022)

11.14.5 Kwangdong Recent Development

11.15 GW Pharmaceuticals

11.15.1 GW Pharmaceuticals Company Detail

11.15.2 GW Pharmaceuticals Business Overview

11.15.3 GW Pharmaceuticals Botanical Drug Introduction

11.15.4 GW Pharmaceuticals Revenue in Botanical Drug Business (2017-2022)

11.15.5 GW Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

Choose License Type

Checkout Inquiry Sample